Study at ASCO plenary:Radiation can be omitted for some rectal cancer patients June 09, 2023Vol.49 No.23By Jacquelyn Cobb
ComboMATCH trial—a collaboration across NCI and NCTN groups—matches patients with combination therapy trials based on tumor biology June 02, 2023Vol.49 No.22By Jacquelyn Cobb
Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die May 26, 2023Vol.49 No.21By Paul Goldberg
Trials & Tribulations Continuous temperature tracking helps manage infection risk after CAR T-cell therapy May 05, 2023Vol.49 No.18By Ruth Phillips
Trials & Tribulations San Antonio Breast Cancer Symposium 2022 tackled big obstacles, recommended solutions for breast cancer progress April 14, 2023Vol.49 No.15By Angela DeMichele, Rajarshi Sengupta and Carlos L. Arteaga
Pragmatica-Lung, a landmark pragmatic trial with registrational intent, starts enrollment April 14, 2023Vol.49 No.15By Jacquelyn Cobb
Trials & Tribulations Does salpingectomy prevent ovarian cancer? Let’s prove it.The SOROCk clinical trial, NRG CC008 (NCT04251052) March 17, 2023Vol.49 No.11By Kathryn P. Pennington, Warner K. Huh, Sandra Russo and Joan L. Walker
Cancer patients have sevenfold suicide risk in first six months after diagnosis March 03, 2023Vol.49 No.09By Jacquelyn Cobb
Grant-funded, investigator-initiated trials fail to bounce back from COVID as 50% of research staff left for higher-paying jobs February 17, 2023Vol.49 No.07By Matthew Bin Han Ong
Trials & Tribulations MRI-guided radiotherapy for prostate cancer: Lessons from the MIRAGE trial February 03, 2023Vol.49 No.05By Amar U. Kishan
